PureTech Health reports positive Phase 1b data for LYT-200 in MDS and AML

European Commission approves Ojemda as first targeted therapy for relapsed paediatric low-grade glioma

Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning

Ondine Biomedical abstracts selected for 2026 World Congress on Infectious Diseases

hVIVO secures Phase III human challenge trial contract with ILiAD Biotechnologies

FDA expands approval of Sanofi's Tzield for early-stage type 1 diabetes in young children

Inhibrx provides clinical update on ozekibart (INBRX-109) for colorectal cancer treatment

Lytix reports phase II results showing durable responses in advanced melanoma

Rznomics reports RZ-001 interim clinical data in hepatocellular carcinoma at AACR 2026

Akeso presents positive Phase II results from cadonilimab combination study at AACR 2026

LENZ Therapeutics advances VIZZ regulatory expansion with UK submission for presbyopia treatment

GSK secures China approval for Blenrep in relapsed multiple myeloma

Sanofi's Nuvaxovid demonstrates superior tolerability to Moderna's mNEXSPIKE in phase 4 study

AstraZeneca reports third positive Phase III trial for tozorakimab in COPD

TheraCryf advances Ox-1 programme to clinical stage following successful GMP manufacture